← All trials
NCT06746519
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 25, 2024
- Primary completion
- Dec 30, 2025
- Completion date
- Jun 30, 2027
- First posted
- Dec 24, 2024
- Last posted
- Dec 24, 2024
- Enrollment
- 135
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Soochow UniversityLead sponsor
- Soochow UniversitySponsor investigator
- BioNova Pharmaceuticals (Shanghai) LTD.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.